Close

Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Regenerative Medicine Makeover Via Artificial Intelligence

While the regenerative medicine spectrum continues its upward trend,...

By 2033, World Market For APIs Could Reach US$ 384 Billion

The worldwide active pharmaceutical ingredient market size happened to...

Market Forecast For Innovative Small Molecule Injectables

A Business Research Company report goes on to predict...

Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a conference call at 10:30 a.m. EDT on July 28, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call athttp://investor.bms.com or by dialing in the U.S. toll free 877-201-0168 or international 647-788-4901, confirmation code: 91350399. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:30 p.m. EDT on July 28 through 11:59 p.m. EDT on August 11, 2016. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 855-859-2056 or international 404-537-3406, confirmation code: 91350399.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Contact:

Bristol-Myers Squibb Company
Media: 
Ken Dominski, 609-252-5251
ken.dominski@bms.com

or

Lisa McCormick Lavery, 609-252-7602
lisa.mccormicklavery@bms.com

or
 
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

or

Ranya Dajani, 609-252-5330
ranya.dajani@bms.com

or

Bill Szablewski, 609-252-5894
william.szablewski@bms.com
 

Latest stories

Related stories

Regenerative Medicine Makeover Via Artificial Intelligence

While the regenerative medicine spectrum continues its upward trend,...

By 2033, World Market For APIs Could Reach US$ 384 Billion

The worldwide active pharmaceutical ingredient market size happened to...

Market Forecast For Innovative Small Molecule Injectables

A Business Research Company report goes on to predict...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back